Latest News and Press Releases

VedTechBio enhances RxAgentAI platform; teams with US-based AlphaMeld to cut drug discovery time and co-develop therapies for rare and metabolic diseases.

VedTechBio enhances RxAgentAI platform; teams with US-based AlphaMeld to cut drug discovery time and co-develop therapies for rare and metabolic diseases.

Dublin, July 17, 2025 (GLOBE NEWSWIRE) -- The "AI in Pharmacovigilance Training Course" has been added to ResearchAndMarkets.com's offering. This course will provide a comprehensive introduction...

Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "AI-Enabled Drug Discovery and Clinical Trials Market Report 2025-2035" report has been added to ResearchAndMarkets.com's offering.Overall world...

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Drug Discovery Market - Global Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's...

Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Generative AI in Drug Discovery" training has been added to ResearchAndMarkets.com's offering. The US FDA's encouragement of AI technology in...

Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "AI in Pharmacovigilance Training Course" has been added to ResearchAndMarkets.com's offering. This course will provide a comprehensive introduction...

Pune, Jan. 13, 2025 (GLOBE NEWSWIRE) -- “According to SNS Insider, The Artificial Intelligence in Drug Discovery Market was valued at USD 1.48 billion in 2023 and is expected to reach USD 15.50...

Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: AI in drug discovery" report has been added to ResearchAndMarkets.com's offering. This report consolidates the latest...

Pune, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Generative AI in Healthcare Market Size & Growth Analysis: According to SNS Insider, the Generative AI in Healthcare Market was valued at USD 1.7 billion...